scispace - formally typeset
Open AccessJournal ArticleDOI

Angioedema in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

Linda B. Piller, +8 more
- 01 May 2005 - 
- Vol. 18, Iss: 5
Reads0
Chats0
About: 
This article is published in American Journal of Hypertension.The article was published on 2005-05-01 and is currently open access. It has received 2 citations till now. The article focuses on the topics: Lisinopril & Chlorthalidone.

read more

Citations
More filters

Angioedem uzrokovan lijekovima koji djeluju na angiotenzinski sustav Angioedema Caused by Agents Acting on the Angiotensin System

Tanja Batinac
TL;DR: In this paper, Blokatori reninsko-angiotenzinskog sustava (RAS) cesto su primjenjivani lijekovi s dokazanim pozitivnim utjecajem na kardiovaskularne i bubrežne bolesti.
Book ChapterDOI

20 - Antihypertensive drugs

Jamie J Coleman
TL;DR: This chapter describes the various aspects of antihypertensive drugs, and the pathophysiological mechanism has been related to bradykinin accumulation, release of IgE, and mast cell-mediated release of vasoactive mediators.
Related Papers (5)

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)

Curt D. Furberg, +56 more
- 18 Dec 2002 - 

Incidence and Predictors of Angioedema in Elderly Hypertensive Patients at High Risk for Cardiovascular Disease: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Linda B. Piller, +7 more
- 01 Sep 2006 - 

`Size is not everything`: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic. The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)

Gordon T. McInnes
- 01 Jul 2003 - 

Hypertension and atherosclerosis: Clinical implications from the ALLHAT trial

John B Standridge
- 01 Mar 2005 - 

The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic.

John M. Flack, +2 more
- 01 Jun 2003 -